Search results
Results from the WOW.Com Content Network
Year of discovery Name of the drug Active ingredients 1st millennium BC: Hyoscyamus niger: Tropane alkaloids (e.g. hyoscyamine and scopolamine). [16] 600 B.C. Glycerol, produced: Glycerol [citation needed] 300 B.C. Opium: Phenanthrenes (e.g. morphine, codeine, and thebaine). [17] Morphine binds to and activates Mu opioid receptors and is analgesic.
Despite the rise of combinatorial chemistry as an integral part of lead discovery process, natural products still play a major role as starting material for drug discovery. [56] A 2007 report [ 57 ] found that of the 974 small molecule new chemical entities developed between 1981 and 2006, 63% were natural derived or semisynthetic derivatives ...
This is a list of notable medical and scientific journals that publish articles in pharmacology and the pharmaceutical sciences This is a dynamic list and may never be able to satisfy particular standards for completeness.
This is the timeline of modern [clarification needed] antimicrobial [clarification needed] (anti-infective) therapy. The years show when a given drug was released onto the pharmaceutical market. This is not a timeline of the development of the antibiotics themselves.
Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of medicine or any medical specialty. Journals are listed alphabetically by journal name, and also grouped by the subfield of medicine they focus on.
AI in drug development successes The world's first COVID-19 drug designed by generative AI is approved for human use, with clinical trials expected to begin in China. The new drug, ISM3312, is developed by Insilico Medicine. [389] A new AI algorithm developed by Baidu is shown to boost the antibody response of COVID-19 mRNA vaccines by 128 ...
Current Opinion is a series of medical journals published by Current Drugs from 1998 to 2010. Current Drugs was acquired by Thomson Corporation in 2004. [1] Journals in the series included: Current Opinion in Drug Discovery & Development (ISSN 1367-6733)
Forward (classical) and reverse pharmacology approaches in drug discovery. In the field of drug discovery, classical pharmacology, [1] also known as forward pharmacology, [2] [3] [4] or phenotypic drug discovery (PDD), [5] relies on phenotypic screening (screening in intact cells or whole organisms) of chemical libraries of synthetic small molecules, natural products or extracts to identify ...